Literature DB >> 17558704

Hematological presentation in systemic lupus erythematosus and its relationship with disease activity.

Eśin Beyan1, Cengiz Beyan, Mustafa Turan.   

Abstract

Abnormalities of hematological system are very common in systemic lupus erythematosus (SLE). The aim of the study is to evaluate hematological findings in patients with SLE at the time of referral and their relationship with disease activity and organ involvement. The study was carried consecutive 115 patients, including 20 males and 85 females. Most of the cases had anemia at the time of presentation due to various etiologies. Anemia of chronic disease was seen in 46% and it was the most common encountered picture. The rate of hemolytic anemia was 28%, and Coombs' positivity rate was 22% among our patients. Leukopenia ( < 4.0 x 10(9)/l), neutropenia ( < 1.8 x 10(9)/l), and lymphopenia ( < 1.5 x 10(9)/l) rates were 57, 20, and 82%, respectively. Thrombocytopenia was seen in 40% for < 150 x 10(9)/l, 26% for < 100 x 10(9)/l, and 8% for < 50 x 10(9)/l. Of our patients, 10% had antiphospholipid syndrome (APS) at the time of diagnosis. Increased fibrinogen levels were observed in 35% without relating to disease activity. The rates of C3 and C4 hypocomplementemia were 86 and 64%, respectively, and both are closely correlated with the disease activity. Moreover, C3 hypocomplementemia was more prominent in cases with renal or serosal involvement. Leukopenia and hyperfibrinogenemia were more common in patients with skin/mucosal involvements. C3 hypocomplementemia, APS and elevated IgG levels were more common in our patients with renal involvement. SLE should be kept in mind while evaluating patients with mentioned hematological findings, especially in those with accompanying organ involvements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558704     DOI: 10.1080/10245330701214145

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  16 in total

1.  Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients.

Authors:  Hava Üsküdar Teke; Döndü Üsküdar Cansu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2017-04-11

2.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

Review 3.  The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.

Authors:  Gholam-Hossein Alishiri; Amin Saburi; Noushin Bayat; Ali-Reza Saadat; Ehsan Saburi
Journal:  Clin Rheumatol       Date:  2011-10-21       Impact factor: 2.980

4.  Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus.

Authors:  Linnette López-López; Noridza Rivera-Rodríguez; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2012-09-12

5.  Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective.

Authors:  M Jeffries; F Hamadeh; T Aberle; S Glenn; D L Kamen; J A Kelly; M Reichlin; J B Harley; A H Sawalha
Journal:  Lupus       Date:  2008-08       Impact factor: 2.911

6.  Anaemia in Systemic Lupus Erythematosus Based on Iron Studies and Soluble Transferrin Receptor Levels.

Authors:  Salony Mittal; Preeti Agarwal; Anupam Wakhlu; Ashutosh Kumar; Raj Mehrotra; Saumya Mittal
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Outcomes in Mild to Moderate Isolated Thrombocytopenia.

Authors:  Charles Schlappi; Varsha Kulkarni; Prasannalaxmi Palabindela; Christina Bemrich-Stolz; Thomas Howard; Lee Hilliard; Jeffrey Lebensburger
Journal:  Pediatrics       Date:  2018-06-11       Impact factor: 7.124

8.  Direct antiglobulin (Coombs) test in systemic lupus erythematosus patients.

Authors:  Thelma Skare; Leandro Picelli; Thiago Alberto G Dos Santos; Renato Nisihara
Journal:  Clin Rheumatol       Date:  2017-07-31       Impact factor: 2.980

Review 9.  Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.

Authors:  Émilie Chalayer; Martine Ffrench; Pascal Cathébras
Journal:  Rheumatol Int       Date:  2014-10-30       Impact factor: 3.580

10.  Hematological Manifestations of SLE at Initial Presentation: Is It Underestimated?

Authors:  P K Sasidharan; M Bindya; K G Sajeeth Kumar
Journal:  ISRN Hematol       Date:  2012-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.